📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Dara Biosciences

1.1 - Company Overview

Dara Biosciences Logo

Dara Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of oncology treatment and supportive care products, dedicated to commercialization as a specialty pharmaceutical company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Dara Biosciences

CiMaas Logo

CiMaas

HQ: The Netherlands Website
  • Description: Provider of immunotherapies engaging the immune system to treat cancers not cured by current standard of care, including CIM201 adoptive NK cell therapy using proprietary NK expansion for high cytotoxicity; CIM101 F012 feeder cells to rapidly expand NK cells under licensing; and CIM401 adoptive CAR-NK therapy targeting solid tumors, initially breast cancer.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CiMaas company profile →
Caelum Biosciences Logo

Caelum Biosciences

HQ: United States Website
  • Description: Provider of clinical-stage biotechnology developing treatments for rare and life-threatening diseases, with lead asset CAEL-101 (mAb 11-1F4), a novel antibody licensed from Columbia University in January 2017 for the treatment of amyloid light chain (AL) amyloidosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Caelum Biosciences company profile →
Kedrion Biopharma Logo

Kedrion Biopharma

HQ: United States Website
  • Description: Provider of plasma-derived medicinal products—clotting factors, albumin, and immunoglobulins—for treating hemophilia and immune deficiencies. Offers contract fractionation/manufacturing, technology transfer to build local plasma collection and fractionation, BioSC virus/prion safety studies (PCR, contaminants in cell cultures, in vitro, protein characterization), and pharmacovigilance.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Kedrion Biopharma company profile →
Trubion Logo

Trubion

HQ: United States Website
  • Description: Provider of biopharmaceutical product candidates for autoimmune diseases and cancer, developing novel single-chain polypeptide proteins built with its SMIP custom drug assembly technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Trubion company profile →
Synthon Logo

Synthon

HQ: The Netherlands Website
  • Description: Provider of affordable generic medicines and pharmaceutical development and manufacturing services, including API development, formulation development (solid oral dose, immediate and modified release, injectables), high-containment compounds for cancer treatment, R&D across multiple countries, and global manufacturing of tablets, capsules, and injectables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synthon company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Dara Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Dara Biosciences

2.2 - Growth funds investing in similar companies to Dara Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Dara Biosciences

4.2 - Public trading comparable groups for Dara Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Dara Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Dara Biosciences

What does Dara Biosciences do?

Dara Biosciences is a provider of oncology treatment and supportive care products, dedicated to commercialization as a specialty pharmaceutical company.

Who are Dara Biosciences's competitors?

Dara Biosciences's competitors and similar companies include CiMaas, Caelum Biosciences, Kedrion Biopharma, Trubion, and Synthon.

Where is Dara Biosciences headquartered?

Dara Biosciences is headquartered in United States.

How many employees does Dara Biosciences have?

Dara Biosciences has 1,000 employees 🔒.

When was Dara Biosciences founded?

Dara Biosciences was founded in 2010 🔒.

What sector and industry vertical is Dara Biosciences in?

Dara Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Dara Biosciences

Who are the top strategic acquirers in Dara Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Dara Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Dara Biosciences?

Top strategic M&A buyers groups and sectors for Dara Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Dara Biosciences's sector and industry vertical

Which are the top PE firms investing in Dara Biosciences's sector and industry vertical?

Top PE firms investing in Dara Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Dara Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Dara Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Dara Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Dara Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Dara Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Dara Biosciences?

The key public trading comparables and valuation benchmarks for Dara Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Dara Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Dara Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Dara Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Dara Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Dara Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Dara Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Dara Biosciences